Elysium Health and the University of Oxford Solve a Big Piece of the Brain Aging Puzzle
Here’s how we partnered with the University of Oxford to slow age-related brain atrophy linked to memory decline. Details on the VITACOG study, which powers Matter:
- LocationConducted at the University of Oxford.
- Participants168 adults, two-year clinical trial
- ProtocolDouble-blind, placebo-controlled, randomized—the “gold standard” in studies.
- ResultsThe B-vitamin complex significantly reduced age-related brain atrophy associated with memory decline. Atrophy was reduced by up to 86% in grey matter regions involved in learning and memory.
Get Started With Matter
Matter reduces age-related brain atrophy in areas that are involved in memory and learning—a major step forward for long-term brain health. Get the proven formulation developed at the University of Oxford.